Costa Bachas
16PUBLICATIONS
34CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (16)
Sort by Publication Date:
|Dec 10, 2025
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia.Lukas H Haaksma, Raffaele Palmieri, Tom Reuvekamp
|Sep 03, 2025
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp
|May 22, 2025
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia.Tim R Mocking, Arjan A van de Loosdrecht, Jacqueline Cloos
|Feb 27, 2025
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents.Tom Reuvekamp, Lok Lam Ngai, Daphne den Hartog
|Dec 20, 2024
Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models.Tim R Mocking, Angèle Kelder, Tom Reuvekamp
Pageof 3
Frequent Collaborators
11 joint publications
Jacqueline Cloos
7 joint publications
Tim R Mocking
7 joint publications
Lok Lam Ngai
6 joint publications
Tom Reuvekamp
6 joint publications
Arjan A van de Loosdrecht
5 joint publications
Jesse M Tettero
4 joint publications
Thomas Pabst
4 joint publications
David C de Leeuw
3 joint publications
Markus G Manz
3 joint publications
Bjørn T Gjertsen